Market Overview

UPDATE: Sterne Agee Downgrades Crocs on Raised Concerns, Lowered Estimates

Share:
Related CROX
Mid-Afternoon Market Update: Gold Futures Down 3.5%; PTC Therapeutics Shares Spike Higher
Stocks Hitting 52-Week Lows

In a report published Thursday, Sterne Agee analyst Sam Poser downgraded Crocs (NASDAQ: CROX) from Neutral to Underperform, and named a $10.00 price target.

In the report, Sterne Agee noted, “Vacate positions in CROX: There is a global senior leadership void. 3 of 5 regions have no director. CROX is selling Crosslite products to Backjoy.com. on terms that may not be at arms' length. Lowering '13/'14 EPS estimates from $1.01/ $1.33 to $0.99/$1.20.”

Crocs closed on Wednesday at $14.01.

Latest Ratings for CROX

DateFirmActionFromTo
Nov 2016Monness Crespi HardtDowngradesBuyNeutral
Aug 2016SusquehannaInitiates Coverage onNeutral
May 2016Sterne Agee CRTUpgradesNeutralBuy

View More Analyst Ratings for CROX
View the Latest Analyst Ratings

Posted-In: Sam Poser Sterne AgeeAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CROX)

View Comments and Join the Discussion!